Finance

Beta
Lists
688117:SHA
ChengDu Sheng Nuo Biotec Co Ltd
CN¥23.04
+0.35%
(+0.080) 1D
Jun 5, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688117...
Open
CN¥23.39
High
CN¥23.78
Low
CN¥22.87
Mkt. cap
5.08B
Avg. vol.
3.04M
Volume
1.72M
Dividend
1.53%
Quarterly dividend
CN¥0.09
Ex-dividend date
Jun 5, 2026
P/E ratio
20.47
52-wk high
CN¥34.26
52-wk low
CN¥20.52
EPS
CN¥1.13
No. of employees
2K
Open
CN¥23.39
High
CN¥23.78
Low
CN¥22.87
Mkt. cap
5.08B
Avg. vol.
3.04M
Volume
1.72M
Dividend
1.53%
Quarterly dividend
CN¥0.09
Ex-dividend date
Jun 5, 2026
P/E ratio
20.47
52-wk high
CN¥34.26
52-wk low
CN¥20.52
EPS
CN¥1.13
No. of employees
2K
News stories
From sources across the web
About ChengDu Sheng Nuo Biotec Co Ltd
CEO-
Employees1.6K
FoundedJul 23, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
153.23M
182.55M
221.34M
244.29M
Cost of goods sold
73.24M
71.21M
103.50M
98.04M
Cost of revenue
73.24M
71.21M
103.50M
98.04M
Research and development expenses
13.30M
18.22M
18.55M
10.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.44M
32.40M
43.94M
46.95M
Operating expense
38.98M
47.73M
74.26M
61.38M
Total operating expenses
112.22M
118.95M
177.75M
159.41M
Operating income
41.02M
63.60M
43.58M
84.87M
Other non operating income
5.01M
-5.93M
-607.69K
370.80K
EBT including unusual items
47.19M
42.96M
43.45M
75.98M
EBT excluding unusual items
42.49M
52.37M
40.47M
80.73M
Income tax expense
5.36M
4.91M
12.53M
9.62M
Effective tax rate
11.35%
11.42%
28.85%
12.66%
Other operating expenses
1.68M
-1.19M
2.99M
1.81M
Net income
41.84M
38.05M
30.91M
66.36M
Net profit margin
27.30%
20.85%
13.97%
27.17%
Earnings per share
-
-
-
-
Interest and investment income
43.58K
107.91K
1.12M
1.94M
Interest expense
-3.77M
-5.22M
-2.86M
-6.45M
Net interest expenses
-3.72M
-5.11M
-1.75M
-4.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
51.71M
72.00M
57.56M
98.85M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more